Healthcare Sector

Members of Parliament invested in the Healthcare Sector

156 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£129.70	199.95%	£209,967.61
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£129.70	181.16%	£196,813.34
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£14,112.00	17.37%	£82,155.69
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£14,112.00	242.86%	£240,000.00
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£14,112.00	264.04%	£254,827.81
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£14,112.00	90.14%	£133,096.20
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£14,112.00	19.86%	£83,900.12
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£14,112.00	429.23%	£370,463.15
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£14,112.00	16.09%	£81,263.57
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£14,112.00	160.51%	£182,359.24
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£14,112.00	18.35%	£82,844.68
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£14,112.00	37.95%	£96,563.05
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£14,112.00	76.29%	£123,402.87
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£14,112.00	380.33%	£336,228.73
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.80	-75.83%	£16,918.43
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£52.37	40.06%	£98,044.93
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£52.37	-1.98%	£68,611.27
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£52.37	22.42%	£85,691.91
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£52.37	32.99%	£93,090.40
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£52.37	23.78%	£86,643.82
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£52.37	32.62%	£92,831.09
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£52.37	17.03%	£81,919.55
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£52.37	18.97%	£83,278.05
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£52.37	40.14%	£98,097.41
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£237.60	43.97%	£100,781.68
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£237.60	93.74%	£135,616.44
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£237.60	226.87%	£228,807.26
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£237.60	289.96%	£272,968.99
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£237.60	46.92%	£102,844.42
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£190.11	163.48%	£184,434.02
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£190.11	-23.61%	£53,469.71
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£280.44	10.75%	£77,524.68
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£280.44	-42.77%	£40,057.95
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£280.44	-47.86%	£36,500.01
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£280.44	-45.88%	£37,882.67
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£280.44	-52.82%	£33,026.24
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,190.49	77.03%	£123,919.02
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£470.21	12.45%	£78,716.93
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£470.21	2.39%	£71,672.11
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£470.21	-19.43%	£56,395.55
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£470.21	1.55%	£71,083.92
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£470.21	-1.51%	£68,944.30
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£119.80	-80.44%	£13,689.19
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£119.80	-62.56%	£26,206.25
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£37.08	2.01%	£71,405.78
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£37.08	-63.54%	£25,524.63
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£37.08	-69.79%	£21,145.42
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£37.08	-72.46%	£19,275.21
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£115.99	-31.00%	£48,300.41
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£115.99	-28.76%	£49,866.72
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£148.19	67.67%	£117,371.58
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£148.19	124.37%	£157,056.07
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£148.19	174.22%	£191,951.64
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£178.00	-21.76%	£54,769.23
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£305.70	21.38%	£84,967.24
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£305.70	-1.28%	£69,107.06
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£305.70	19.51%	£83,655.20
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£305.70	0.89%	£70,623.77
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£305.70	-1.07%	£69,252.43
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£107.19	324.24%	£296,969.07
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£107.19	-1.50%	£68,951.48
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£107.19	225.81%	£228,063.82
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£14.78	-85.40%	£10,223.32
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£27.41	40.24%	£98,170.38
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£27.41	-5.56%	£66,110.16
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£32.34	43.07%	£100,145.80
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£32.34	54.14%	£107,900.75
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£299.57	243.98%	£240,784.26
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£339.76	389.43%	£342,598.69
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£339.76	23.55%	£86,484.37
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£44.75	-6.38%	£65,533.47
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£44.75	-18.56%	£57,006.37
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£16.30	27.24%	£89,071.03
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£86.87	-13.79%	£60,344.35
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£71.86	-9.54%	£63,320.74
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£38.47	-59.62%	£28,265.27
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£176.25	-35.62%	£45,068.49
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£206.23	28.24%	£89,771.16
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£479.93	72.73%	£120,910.92
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£479.93	36.81%	£95,769.83
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£479.93	-12.95%	£60,937.97
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£499.65	1,510.73%	£1,127,514.49
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£24.30	-2.84%	£68,012.25
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,575.00	-3.85%	£67,307.69
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£579.85	1,835.41%	£1,354,789.71
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£917.50	25.46%	£87,819.45
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,245.00	-38.55%	£43,015.79
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£1.00	-97.69%	£1,617.00
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£798.10	43.29%	£100,299.82
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£4.91	250.71%	£245,499.99
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£3.14	63.54%	£114,479.17
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.85	-18.27%	£57,211.54
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£30.36	101.73%	£141,209.31
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.23	-98.08%	£1,341.67
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£10.00	-5.84%	£65,913.37
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£7.75	-31.11%	£48,222.22
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£45.53	51.36%	£105,954.12
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£52.37	-53.23%	£32,737.09
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£379.20	12.82%	£78,976.50
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£4.64	-63.32%	£25,675.89
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£198.70	-4.24%	£67,031.32
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£198.70	-27.27%	£50,911.42
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.57	-97.79%	£1,548.08
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£66.00	-41.07%	£41,250.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£66.00	28.16%	£89,708.74
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£114.33	554.44%	£458,105.36
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£4.04	-86.53%	£9,426.67
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.78	-4.30%	£66,987.34

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.